Kingworld Medicines Group Limited (Stock Code: 01110) released its monthly return for equity securities, covering the period ended 31 January 2026. The announcement highlights that no changes occurred in the company's authorized share capital of HKD 1,000,000,000, which remains divided into 10,000,000,000 ordinary shares at a par value of HKD 0.1.

The total issued share count at the end of January 2026 was 622,500,000 ordinary shares, unchanged from the previous month. The company confirmed compliance with the 25% minimum public float requirement under relevant Hong Kong listing rules. No warrants, convertible instruments, or new share option issuances were reported during the period.